UCSF envisions new hospital after $500M donation

The University of California, San Francisco (UCSF) received a $500 million commitment from the Helen Diller Foundation to help plan and build a new hospital, according to a Feb. 8 release from the university.

This recent sum for the expansion campus comes 13 months after the Diller Foundation’s pledged $500 million to an endowment and innovation funds. UCSF announced the hospital and outpatient complex will be immediately renamed the UCSF Helen Diller Medical Center at Parnassus Heights.

“This incredible commitment sets the stage for a 21st Century hospital that will play a critical role in patient care for San Franciscans and our community, as well as patients from around the nation and the globe who come to UCSF for care, including highly specialized tertiary and quaternary care,” said UCSF Chancellor Sam Hawgood, MBBS. “Most importantly, it will support each patient’s experience at every step, providing a welcoming, patient-centered environment that promotes warmth and respect, upholding the highest standards of hospitality and patient safety, while also incorporating the latest technologies.”

This latest gift brings the total amount pledge by Helen Diller to UCSF to $1.15 billion.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.